New mRNA flu shot passes first safety test in humans
NCT ID NCT05426174
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 27 times
Summary
This early-stage study tested a new mRNA-based flu vaccine in 233 healthy adults aged 18 and older. The goal was to check if the vaccine is safe and triggers an immune response. Participants received one shot and were monitored for side effects like reactions at the injection site or other symptoms. The study is now complete, and results will help decide if further testing is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AES - DRS - Optimal Research_Site 8400001
Peoria, Illinois, 61614-4885, United States
-
AES - DRS - Optimal Research_Site 8400002
Melbourne, Florida, 32934-8172, United States
-
AES - DRS - Optimal Research_Site 8400007
Huntsville, Alabama, 35802, United States
-
Central Phoenix Medical Clinic, LLC_Site: 8400010
Phoenix, Arizona, 85020, United States
-
Optimal Research San Diego, LLC_Site: 8400009
San Diego, California, 92108, United States
-
Synexus Clinical Research_Site 8400003
Cincinnati, Ohio, 45236, United States
Conditions
Explore the condition pages connected to this study.